Exemptia (Adalimumab)

Facts of EXEMPTIA

  • Brand Name: EXEMPTIA
  • Medicine Name: Adalimumab
  • Company Name: Zydus
  • Supplied as:
  • Injection: 40 mg/0.8 mL in a single-use prefilled glass syringe
Get Price
Category:

Description

What is EXEMPTIA ™?

EXEMPTIA is indicated for the treatment of :

  • Rheumatoid Arthritis (RA) : Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA.
  • Juvenile Idiopathic Arthritis (JIA) : Reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older.
  • Psoriatic Arthritis (PsA) : Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA.
  • Ankylosing Spondylitis (AS) : Reducing signs and symptoms in adult patients with active AS.
  • Adult Crohn’s Disease (CD) : Reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy. Reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.
  • Pediatric Crohn’s Disease : Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn’s disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate.
  • Ulcerative Colitis (UC) : Inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to immunosuppressants such as corticosteroids, azathioprine or 6-mercaptopurine (6-MP). The effectiveness of EXEMPTIA has not been established in patients who have lost response to or were intolerant to TNF blockers.

What is the best price of EXEMPTIA 40 mg/0.8 mL?

Please contact +91 8130290915 for EXEMPTIA price in India We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Where can I Buy EXEMPTIA 40 mg/0.8 mL?

The Indian Pharma connects buyer with the supplier who can ship EXEMPTIA to any country of the world as per the buyer’s requirement and Government regulations of the country. EXEMPTIA is manufactured by Zydus. The Indian Pharma provides options of choosing exporter and supplier of cancer treatment medicines. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Availability

Is EXEMPTIA 40 mg/0.8 mL available in India?


EXEMPTIA is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.


You can access medicine in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)


We facilitate by providing:


  • Medicine Price.

  • Finding Genuine and reliable source

  • Ensuring 100% transparency.

EXEMPTIA 40 mg/0.8 mL can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of EXEMPTIA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)


How order will be confirmed?


The order will be confirmed only after the receipt of


  • Valid prescription of Clinician

  • Import permit if applicable

Send your inquiry to find,
EXEMPTIA (Adalimumab)Procarbazine Hydrochloride in China,Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong,UAE, Iraq, Iran, Saudi, Arabia, Jordan,Argentina, Brazil, Chile, Colombia, Peru, Venezuela,Europe, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia,Russia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia,Algeria, Mauritius, Uganda, Zimbabwe,Australia and New Zealand

Immunotherapy Medicine for Cancer


  • Cerdelga® (eliglustat)

  • Xeljanz (Tofacitinib)

  • Avonex (interferon beta 1a)

  • HUMIRA™ (Adalimumab)

  • EXEMPTIA (Adalimumab)

  • Atgam (Anti-thymocyte Globulin )